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Dr Mark Danton (Glasgow, Scotland). We have had experi-
ence with this cannula in neonates and have been concerned about
the incidence of perforation. One case occurred at implantation, as
you have had, but another case occurred late down the line when
the patient was having physiotherapy on the lungs. The cannula
was well placed at the time of implantation with the distal end
in the inferior vena cava but had subsequently migrated, and
with the physiotherapy and the up and downmovement had caused
a right atrial perforation and required repair. So my question to you
is that once you have positioned these catheters, cannulas, do youThe Journal of Thoracic and Casubsequently monitor their position and review their position,
particularly when you are starting to mobilize the patient?
Dr Kon. In our experience, we only had a single perforation. It
was during cannula placement, and that, again, was before fluoros-
copy and transesophageal echocardiography were used in every
case for placement. In regard to movement of the cannula during
physiotherapy, we routinely tunnel our catheter so it is actually
hubbed at the end of the tunnel and secured at that point with
multiple sutures. We then monitor its placement with daily chest
x-rays, which seemed to haveworked, and we haven’t had any can-
nula dislodgement or movement.
Dr Thoralf Sundt (Rochester, Minn). Patients with pulmonary
hypertension are a problem for a lot of us, and that is where we see
the need for ECMO frequently in bridging to transplant. I am a little
confused. Can you help me understand how aVV system helps you
deal with pulmonary hypertension? Usually their mode of exit is
right heart failure.
Dr Kon. That patient actually had a wide open atrial septal
defect, and I guess you could consider it pseudo-venoarterial
ECMO in that patient, because with that central orifice in the right
atrium, it essentially just flows right across into the left atrium,
thereby bypassing the lungs.
Dr Bryan Meyers (St Louis, Mo). This is a type of therapy that
is currently in use for other indications, and what you are propos-
ing in addition to the new technology or the specific technology is
extending the indications, and it is based on an assessment of the
patient’s poor prognosis. I think in other areas we have objective
risk scores. You have 2 intensivists who assure you that the prog-
nosis is poor, but in assessing the value of something like this, it
would be nice to have some objective estimate of that patient’s
prognosis to know what difference you have made when all is
said and done.
Dr Kon. Thank you for the comment. I agree completely.
Dr Bansi Koul (Lund, Sweden). Thanks for a wonderful pre-
sentation and excellent results. My short question to you is about
what I observed from your data that you have increasingly been
using 31F cannulas, especially in the later part of your
experience. Was it because the blood flows were not sufficient
to oxygenate the patient or can you give us some information
idea about the extracorporeal recirculation of the oxygenated
blood within this setup?
DrKon.We did use 31F routinely toward the end of this cohort,
and it was in fact because it is hard to get flows up to 4 liters with
these smaller cannulas, and we had minimal to no recirculation in
this circuit, because the fenestrations sit in the inferior and superior
venae cavae and then the outflow is directly toward the tricuspid
valve.rdiovascular Surgery c Volume 142, Number 4 761
